Screening of SIRT6 inhibitors and activators: A novel activator has an impact on breast cancer cells-Reference-Cited by-同舟云学术

Screening of SIRT6 inhibitors and activators: A novel activator has an impact on breast cancer cells

Published:2021-06 Issue: Volume:138 Page:111452
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Tenhunen Jonna,Kučera Tomáš,Huovinen Marjo,Küblbeck Jenni,Bisenieks Egils,Vigante Brigita,Ogle Zaiga,Duburs Gunars,Doležal Martin,Moaddel Ruin,Lahtela-Kakkonen Maija,Rahnasto-Rilla Minna

Funder

Academy of Finland

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference46 articles.

1. SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin;Michishita;Nature,2008

2. SIRT6 deacetylates H3K18ac at pericentric chromatin to prevent mitotic errors and cellular senescence;Tasselli;Nat. Struct. Mol. Biol.,2016

3. Activation of the protein deacetylase SIRT6 by long-chain fatty acids and widespread deacylation by mammalian sirtuins;Feldman;J. Biol. Chem.,2013

4. SIRT6 regulates Ras-related protein R-Ras2 by lysine defatty-acylation;Zhang;Elife,2017

5. SIRT6 promotes transcription of a subset of NRF2 targets by mono-ADP-ribosylating BAF170;Rezazadeh;Nucleic Acids Res.,2019

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The (patho)physiological roles of the individual deacylase activities of a sirtuin;Chemical Biology & Drug Design;2024-01-29

2. N-Substituted dihydropyridines as promising EGFR tyrosine kinase inhibitors against breast cancer: Design, synthesis, biological evaluation, docking, and molecular dynamics simulations;Results in Chemistry;2024-01

3. Anticancer potential of novel symmetrical and asymmetrical dihydropyridines against breast cancer via EGFR inhibition: molecular design, synthesis, analysis and screening;RSC Advances;2024

4. The Role of Sirtuin 6 in the Deacetylation of Histone Proteins as a Factor in the Progression of Neoplastic Disease;International Journal of Molecular Sciences;2023-12-29

5. SIRT6 promotes metastasis and relapse in HER2-positive breast cancer;Scientific Reports;2023-12-12